What vial volumes (in mL) are commercially available for injectable triamcinolone (e.g., Kenalog‑40, Kenacol‑80)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triamcinolone Vial Volumes

Injectable triamcinolone acetonide is commercially available in 10 mL multi-dose vials containing 40 mg/mL (400 mg total per vial). 1

FDA-Approved Formulations

The FDA-labeled triamcinolone acetonide injectable suspension comes in the following vial size:

  • 10 mL multi-dose vial at 40 mg/mL concentration (providing 400 mg total triamcinolone acetonide per vial) 1

Historical Context and Alternatives

While the standard commercial formulation is 40 mg/mL in 10 mL vials, research has documented that Kenalog-40 (Bristol-Myers-Squibb) was historically supplied as 0.1 mL single-dose vials containing 40 mg for certain applications. 2 However, this smaller vial size is not the current standard FDA-approved packaging described in the drug label. 1

Preservative-Free Formulations

For specialized applications (particularly intravitreal use), preservative-free formulations have been prepared in research settings at concentrations of 40 mg/mL or 160 mg/mL in single-use vials, though these are not standard commercial products. 3 These preparations were developed specifically to avoid benzyl alcohol toxicity in ocular tissues. 4, 3

Storage Requirements

  • Store at 20° to 25°C (68° to 77°F) 1
  • Protect from temperatures below 20°C (68°F) 1
  • Store vial in carton to protect from light 1
  • Store vial upright 1
  • Discard unused portions of single-dose vials 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.